Entrada Therapeutics annual net debt
2021
2022
2023
2024
2025
Entrada Therapeutics Net Debt Growth & History (TRDA)
Entrada Therapeutics's net debt was −$39.5M for fiscal 2025.
View full Entrada Therapeutics company overviewEntrada Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$39.5M | $2.5M | — |
| 2024 | 2024-12-31 | −$42.0M | −$42.6M | — |
| 2023 | 2023-12-31 | $628,000 | $19.8M | — |
| 2022 | 2022-12-31 | −$19.2M | $271.8M | — |
| 2021 | 2021-12-31 | −$291.1M | — | — |
Entrada Therapeutics quarterly net debt
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$50.7M | −$33.0M | — |
| Q1 2026 | 2026-03-31 | −$26.7M | −$15.9M | — |
| Q4 2025 | 2025-12-31 | −$39.5M | $2.5M | — |
| Q3 2025 | 2025-09-30 | −$40.9M | −$24.2M | — |
| Q2 2025 | 2025-06-30 | −$17.7M | $103.1M | — |
| Q1 2025 | 2025-03-31 | −$10.8M | −$8.8M | — |
| Q4 2024 | 2024-12-31 | −$42.0M | −$42.6M | — |
| Q3 2024 | 2024-09-30 | −$16.7M | −$33.9M | — |
| Q2 2024 | 2024-06-30 | −$120.8M | −$114.1M | — |
| Q1 2024 | 2024-03-31 | −$2.0M | $209.4M | — |
| Q4 2023 | 2023-12-31 | $628,000 | $19.8M | — |
| Q3 2023 | 2023-09-30 | $17.2M | $42.6M | — |
| Q2 2023 | 2023-06-30 | −$6.7M | $54.2M | — |
| Q1 2023 | 2023-03-31 | −$211.4M | −$158.6M | — |
| Q4 2022 | 2022-12-31 | −$19.2M | $271.8M | — |
| Q3 2022 | 2022-09-30 | −$25.4M | — | — |
| Q2 2022 | 2022-06-30 | −$61.0M | — | — |
| Q1 2022 | 2022-03-31 | −$52.8M | — | — |
| Q4 2021 | 2021-12-31 | −$291.1M | — | — |
Entrada Therapeutics net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Entrada Therapeutics's net debt increased from −$291.1M to −$39.5M, a change of $251.6M. The latest reported quarter, Q2 2026, shows −$50.7M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Entrada Therapeutics source filings ↗